BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26356816)

  • 1. C-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model.
    Tan J; Yang S; Shen P; Sun H; Xiao J; Wang Y; Wu B; Ji F; Yan J; Xue H; Zhou D
    Oncotarget; 2015 Sep; 6(29):27037-48. PubMed ID: 26356816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCF/c-KIT Signaling Increased Mucin2 Production by Maintaining Atoh1 Expression in Mucinous Colorectal Adenocarcinoma.
    Shen P; Yang S; Sun H; Li G; Wu B; Ji F; Sun T; Zhou D
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C-δ-mediated recycling of active KIT in colon cancer.
    Park M; Kim WK; Song M; Park M; Kim H; Nam HJ; Baek SH; Kim H
    Clin Cancer Res; 2013 Sep; 19(18):4961-71. PubMed ID: 23881925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCF/C-Kit/JNK/AP-1 Signaling Pathway Promotes Claudin-3 Expression in Colonic Epithelium and Colorectal Carcinoma.
    Wang Y; Sun T; Sun H; Yang S; Li D; Zhou D
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model.
    Tang FY; Pai MH; Chiang EP
    J Nutr Biochem; 2012 Oct; 23(10):1302-13. PubMed ID: 22221675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
    Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
    Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expressions of c-KIT and DOG-1 in mucinous and nonmucinous colorectal carcinomas and relation to clinicopathologic features and prognosis.
    Foda AA; Mohamed MA
    Ann Diagn Pathol; 2015 Oct; 19(5):335-40. PubMed ID: 26272691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
    Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
    World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
    Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway.
    Song J; Zhang J; Wang J; Wang J; Guo X; Dong W
    Tumour Biol; 2015 Mar; 36(3):2013-21. PubMed ID: 25387809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gab3 is required for human colorectal cancer cell proliferation.
    Xiang S; Wang N; Hui P; Ma J
    Biochem Biophys Res Commun; 2017 Mar; 484(4):719-725. PubMed ID: 28115166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.